Obi Mukosolu F, Reinberg Palmar Arianna, Namireddy Vikhyath, Campos Frederick N, Cho Hyun Joon
Internal Medicine, Wyckoff Heights Medical Center, Brooklyn, USA.
Medicine, St. George's University School of Medicine, True Blue, GRD.
Cureus. 2023 May 4;15(5):e38536. doi: 10.7759/cureus.38536. eCollection 2023 May.
Atrial fibrillation (AFib) is a common type of cardiac arrhythmia, characterized by disorganized atrial electrical activity with features of irregularly irregular heart rhythm and often with rapid ventricular response increasing the risk of stroke and heart failure due to tachyarrhythmia. The pathophysiology mechanism of AFib is either triggered by atrial distension, abnormality in conducting system, catecholamine excess, or increased atrial irritation or automaticity. Risk factors include uncontrolled diabetes, obesity, obstructive sleep apnea, hypothyroidism, and certain stimulants. Based on recent research, liver disease has recently been identified as a risk factor for AFib. Considering the progression of chronic liver disease, this literature review aims to investigate and summarize the relationship between liver disease and AFib and explore clinical interventions that can be utilized to prevent AFib aggravation.
心房颤动（AFib）是一种常见的心律失常类型，其特征是心房电活动紊乱，具有心律绝对不齐的特点，且常伴有快速心室反应，增加了因快速性心律失常导致中风和心力衰竭的风险。AFib的病理生理机制要么由心房扩张、传导系统异常、儿茶酚胺过量、心房刺激增加或自律性增加引发。危险因素包括未控制的糖尿病、肥胖、阻塞性睡眠呼吸暂停、甲状腺功能减退以及某些兴奋剂。基于最近的研究，肝病最近已被确定为AFib的一个危险因素。考虑到慢性肝病的进展，本综述旨在调查和总结肝病与AFib之间的关系，并探索可用于预防AFib加重的临床干预措施。
